{
  "report_rows": [
    {
      "kpi": "Adjusted operating EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.070 vs. cons $1.076",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total organic revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.200B vs. cons $1.202B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDAC",
      "prediction": "MISS",
      "answer": "pred ~$595M vs. cons $601M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Contingent commissions (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide qualitative up year/year vs. cons $302M",
      "confidence": "LOW"
    },
    {
      "kpi": "Accession adjusted EBITDAC margin (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~35% vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Accession EBITDA synergies (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$30M-$40M vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.5,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 modest estimate pressure, but a lower long-term multiple and elevated short base limit follow-through",
  "day5_confidence": "LOW"
}